stars 1 stars 2 stars 3

CELLIPSE is a drug discovery company based in Grenoble, France dedicated to bringing innovative therapies to cancer patients and healthcare professionals. We are building a pipeline of small molecules targeting the cytoskeleton (i.e. microtubules and actin filaments) based on our « cell to drug discovery » approach.

CELLIPSE Questions

The CELLIPSE annual revenue was $400000 in 2026.

CELLIPSE is based in Grenoble, Auvergne-Rhone-Alpes.

The NAICS codes for CELLIPSE are [3254, 32541, 325, 54, 32, 541].

The SIC codes for CELLIPSE are [283, 28, 2834].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users